however the share of outofpocket payment for pharmaceuticals is high accounting for of current health expenditure compared with the oecd average of this suggests access to pharmaceuticals can be challenging in the country particularly among lowincome groups data on pharmaceutical consumption and sales are limited in latvia but the only available data for international comparisons show that sales of antibacterials for systemic use measured in defined daily dose ddd are about lower than the oecd average